1. Block KI, Burns BL, Cohen AJ, Dobs AS, Hess SM, Vickers A. Point-counterpoint: using randomized trials for the evaluation of integrative cancer therapies. Integr Cancer Ther. 2004;1(1):66-81.
2.
2. Mills N, Donovan JL, Smith M, Jacoby A, Neal DE, Hamdy FC. Perceptions of equipoise are crucial to trial participation: a qualitative study of men in the ProtecT study. Control Clin Trials. 2003;24(3):272-282.
3.
3. Miller FG, Emanuel EJ, Rosenstein DL, Straus SE. Ethical issues concerning research in complementary and alternative medicine. JAMA. 2004;291(5):599-604.
4.
4. Homer CS. Using the Zelen design in randomized controlled trials: debates and controversies. J Adv Nurs. 2002;38(2):200-207.
5.
5. Vineberg A. Development of anastomosis between coronary vessels and transplanted mammary artery. Med Assoc J. 1954;71:594-596.
6.
6. Thomas JL. The Vineberg legacy: internal mammary artery implantation from inception to obsolescence. Tex Heart Inst J. 1999;26(2):107-113.
7.
7. Cobb LA, Thomas GI, Dillard DH, Merendino KA, Bruce RA. An evaluation of internal-mammary-artery ligation by a doubleblind technic. N Engl J Med. 1959;260(22):1115-1118.
8.
8. Palmer CR. Ethics, data-dependent designs, and the strategy of clinical trials: time to start learning-as-we-go? Stat Methods Med Res. 2002;11(5):381-402.
9.
9. Homer CS. Using the Zelen design in randomized controlled trials: debates and controversies. J Adv Nurs. 2002;38(2):200-207.
10.
10. Snowdon C, Elbourne D, Garcia J. Zelen randomization: attitudes of parents participating in a neonatal clinical trial. Control Clin Trials. 1999;20(2):149-171.
11.
11. Moerman DE, Jonas WB. Deconstructing the placebo effect and finding the meaning response. Ann Intern Med. 2002;136(6): 471-476.
12.
12. Siegel B. Love, Medicine and Miracles. New York: Harper & Rowe; 1986.
